| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
UltraRapid Communications |
From the Edwin L. Steele Laboratory (D.F., A.U., D.G.D., L.X., J.T., I.G., R.K.J.), Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Mass; Department of Medicine (K.K.C.), University of Cambridge, Cambridge, UK. Present address of A.U. is the Department of Environmental Health, National Institute of Public Health, Tokyo, Japan.
Correspondence to Rakesh K. Jain, Department of Radiation Oncology, Massachusetts General Hospital, 100 Blossom St, COX-7, Boston, MA 02114. E-mail jain{at}steele.mgh.harvard.edu
With an increasing incidence of obesity worldwide, rational strategies are needed to control adipogenesis. Growth of any tissue requires the formation of a functional and mature vasculature. To gain mechanistic insight into the link between active adipogenesis and angiogenesis, we developed a model to visualize noninvasively and in real time both angiogenesis and adipogenesis using intravital microscopy. Implanted murine preadipocytes induced vigorous angiogenesis and formed fat pads in a mouse dorsal skin-fold chamber. The newly formed vessels subsequently remodeled into a mature network consisting of arterioles, capillaries, and venules, whereas the preadipocytes differentiated into adipocytes as confirmed by increased aP2 expression. Inhibition of adipocyte differentiation by transfection of preadipocytes with a peroxisome proliferator-activated receptor
dominant-negative construct not only abrogated fat tissue formation but also reduced angiogenesis. Surprisingly, inhibition of angiogenesis by vascular endothelial growth factor receptor-2 (VEGFR2) blocking antibody not only reduced angiogenesis and tissue growth but also inhibited preadipocyte differentiation. We found that part of this inhibition stems from the paracrine interaction between endothelial cells and preadipocytes and that VEGFVEGFR2 signaling in endothelial cells, but not preadipocytes, mediates this process. These findings reveal a reciprocal regulation of adipogenesis and angiogenesis, and suggest that blockade of VEGF signaling can inhibit in vivo adipose tissue formation. The full text of this article is available online at http://www.circresaha.org.
Key Words: obesity adipogenesis angiogenesis vascular endothelial growth factor peroxisome proliferator-activated receptor 
This article has been cited by other articles:
![]() |
H. R. Lijnen Angiogenesis and obesity Cardiovasc Res, May 1, 2008; 78(2): 286 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rophael, R. O. Craft, J. A. Palmer, A. J. Hussey, G. P.L. Thomas, W. A. Morrison, A. J. Penington, and G. M. Mitchell Angiogenic Growth Factor Synergism in a Murine Tissue Engineering Model of Angiogenesis and Adipogenesis Am. J. Pathol., December 1, 2007; 171(6): 2048 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rega, C. Kaun, S. Demyanets, S. Pfaffenberger, K. Rychli, P.J. Hohensinner, S.P. Kastl, W.S. Speidl, T.W. Weiss, J.M. Breuss, et al. Vascular Endothelial Growth Factor Is Induced by the Inflammatory Cytokines Interleukin-6 and Oncostatin M in Human Adipose Tissue In Vitro and in Murine Adipose Tissue In Vivo Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1587 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nishimura, I. Manabe, M. Nagasaki, Y. Hosoya, H. Yamashita, H. Fujita, M. Ohsugi, K. Tobe, T. Kadowaki, R. Nagai, et al. Adipogenesis in Obesity Requires Close Interplay Between Differentiating Adipocytes, Stromal Cells, and Blood Vessels Diabetes, June 1, 2007; 56(6): 1517 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kawai, N. Namba, S. Mushiake, Y. Etani, R. Nishimura, M. Makishima, and K. Ozono Growth hormone stimulates adipogenesis of 3T3-L1 cells through activation of the Stat5A/5B-PPAR{gamma} pathway J. Mol. Endocrinol., January 1, 2007; 38(1): 19 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Cho, H.-K. Sung, K.-T. Kim, H. G. Cheon, G. T. Oh, H. J. Hong, O.-J. Yoo, and G. Y. Koh COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model PNAS, March 28, 2006; 103(13): 4946 - 4951. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Anghelina, P. Krishnan, L. Moldovan, and N. I. Moldovan Monocytes/Macrophages Cooperate with Progenitor Cells during Neovascularization and Tissue Repair: Conversion of Cell Columns into Fibrovascular Bundles Am. J. Pathol., February 1, 2006; 168(2): 529 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakagami, K. Maeda, R. Morishita, S. Iguchi, T. Nishikawa, Y. Takami, Y. Kikuchi, Y. Saito, K. Tamai, T. Ogihara, et al. Novel Autologous Cell Therapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue-Derived Stromal Cells Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2542 - 2547. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Howe, S.-H. Chang, K. C. Tolle, R. Dillon, L. J.T. Young, R. D. Cardiff, R. A. Newman, P. Yang, H. T. Thaler, W. J. Muller, et al. HER2/neu-Induced Mammary Tumorigenesis and Angiogenesis Are Reduced in Cyclooxygenase-2 Knockout Mice Cancer Res., November 1, 2005; 65(21): 10113 - 10119. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chigurupati, T. Kulkarni, S. Thomas, and G. Shah Calcitonin Stimulates Multiple Stages of Angiogenesis by Directly Acting on Endothelial Cells Cancer Res., September 15, 2005; 65(18): 8519 - 8529. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Duda, D. Fukumura, L. L. Munn, M. F. Booth, E. B. Brown, P. Huang, B. Seed, and R. K. Jain Differential Transplantability of Tumor-Associated Stromal Cells Cancer Res., September 1, 2004; 64(17): 5920 - 5924. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rehman, D. Traktuev, J. Li, S. Merfeld-Clauss, C. J. Temm-Grove, J. E. Bovenkerk, C. L. Pell, B. H. Johnstone, R. V. Considine, and K. L. March Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells Circulation, March 16, 2004; 109(10): 1292 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Werner and G. Nickenig From Fat Fighter to Risk Factor: The Zigzag Trek of Leptin Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 7 - 9. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |